Impaired Function is a Common Feature of Neuropathy-Associated Glycyl-tRNA Synthetase Mutations
Open Access
- 28 August 2014
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 35 (11) , 1363-1371
Abstract
C harcot–M arie–T ooth disease type 2D (CMT 2D ) is an autosomal‐dominant axonal peripheral neuropathy characterized by impaired motor and sensory function in the distal extremities. Mutations in the glycyl‐tRNA synthetase (GARS ) gene cause CMT 2D . GARS is a member of the ubiquitously expressed aminoacyl‐tRNA synthetase (ARS ) family and is responsible for charging tRNA with glycine. To date, 13 GARS mutations have been identified in patients with CMT disease. While functional studies have revealed loss‐of‐function characteristics, only four GARS mutations have been rigorously studied. Here, we report the functional evaluation of nine CMT ‐associated GARS mutations in tRNA charging, yeast complementation, and subcellular localization assays. Our results demonstrate that impaired function is a common characteristic of CMT ‐associated GARS mutations. Additionally, one mutation previously associated with CMT disease (p.S er581L eu) does not demonstrate impaired function, was identified in the general population, and failed to segregate with disease in two newly identified families with CMT disease. Thus, we propose that this variant is not a disease‐causing mutation. Together, our data indicate that impaired function is a key component of GARS ‐mediated CMT disease and emphasize the need for careful genetic and functional evaluation before implicating a variant in disease onset.Keywords
Funding Information
- Muscular Dystrophy Association (MDA294479)
- National Institute of Neurological Disorders and Stroke (NS075764)
- National Institute of Neurological Disorders and Stroke (NS065712)
- Charcot-Marie-Tooth Association
This publication has 51 references indexed in Scilit:
- Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational openingProceedings of the National Academy of Sciences, 2011
- The Survival of Motor Neuron (SMN) Protein Interacts with the mRNA-Binding Protein HuD and Regulates Localization of Poly(A) mRNA in Primary Motor Neuron AxonsThe Journal of Neuroscience, 2011
- Compound Heterozygosity for Loss-of-Function Lysyl-tRNA Synthetase Mutations in a Patient with Peripheral NeuropathyThe American Journal of Human Genetics, 2010
- A Major Determinant for Binding and Aminoacylation of tRNAAla in Cytoplasmic Alanyl-tRNA Synthetase Is Mutated in Dominant Axonal Charcot-Marie-Tooth DiseaseThe American Journal of Human Genetics, 2010
- The Role of Aminoacyl-tRNA Synthetases in Genetic DiseasesAnnual Review of Genomics and Human Genetics, 2008
- Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndromeJournal of the Neurological Sciences, 2007
- Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2ANature Genetics, 2004
- Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneityneurogenetics, 1997
- Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D)Human Molecular Genetics, 1996
- An unusual RNA tertiary interaction has a role for the specific aminoacylation of a transfer RNA.Proceedings of the National Academy of Sciences, 1993